id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-D-0197-0003,FDA,FDA-2001-D-0197,"Statistical Approaches To Establishing Bioequivalence; Draft Guidance for
Industry; Availability",Other,Guidance,2022-12-05T05:00:00Z,2022,12,2022-12-05T05:00:00Z,2023-02-04T04:59:59Z,2024-11-07T00:44:45Z,,1,0,0900006485519806
FDA-2001-D-0197-0002,FDA,FDA-2001-D-0197,"Statistical Approaches To Establishing Bioequivalence; Draft Guidance for
Industry; Availability",Notice,Notice of Availability,2022-12-05T05:00:00Z,2022,12,2022-12-05T05:00:00Z,,2022-12-05T13:39:43Z,2022-26414,0,0,09000064855195b1
FDA-2001-D-0197-0001,FDA,FDA-2001-D-0197,Guidance for Industry on Statistical Approaches to Establishing Bioequivalence; Availability,Notice,Notice of Availability,2001-02-09T05:00:00Z,2001,2,,,2024-11-07T21:53:21Z,,1,0,09000064804e30cc